Bioventus Class A Inc (BVS)

Cost of Revenue

$186.20M

TTM · Period ending: · USD

BVS logo

BVS Cost of Revenue

Latest reported$186.20M
BVS TTM Cost of Revenue ($90.94M → $186.20M)
High-resolution chart · PNG

BVS cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bioventus Class A Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
186,204,000
185,671,000
185,657,000
186,228,000
185,821,000
186,390,000
185,054,000
183,190,000
179,721,000
180,089,000
184,152,000
186,675,000
188,858,000
184,589,000
181,037,000
172,038,000
157,732,000
147,558,000
128,192,000
110,667,000
104,290,000
88,455,000
87,642,000
86,646,000
84,886,000
89,781,000
90,935,000
86,045,000
81,168,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.